In vivo generated human CAR T cells eradicate tumor cells
Author:
Affiliation:
1. Molecular Biotechnology and Gene Therapy, Paul-Ehrlich-Institut, Langen, Germany
2. Frankfurt Cancer Institute, Goethe University, Frankfurt am Main, Germany
Publisher
Informa UK Limited
Subject
Oncology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2019.1671761
Reference21 articles.
1. CAR T cell immunotherapy for human cancer
2. Chimeric Antigen Receptor Therapy
3. Chimeric antigen receptor T-cells for B-cell malignancies
4. Extracellular Production of a Potent and Chemically Resistant Nattokinase in Immobilized Escherichia coli Using Response Surface Methodology
5. Clinical development of CAR T cells—challenges and opportunities in translating innovative treatment concepts
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment;eBioMedicine;2024-08
2. In vivo gene delivery to immune cells;Current Opinion in Biotechnology;2024-08
3. Implantable CAR T cell factories enhance solid tumor treatment;Biomaterials;2024-07
4. The Emergence of a Novel Anti-Neoplastic Era in Gene Therapy for Cancer: A Review Study;European Journal of Theoretical and Applied Sciences;2024-07-01
5. T-Cell Differentiation from Hematopoietic Progenitor Cells Using 3D Thymic-like Hydrogels;GEN Biotechnology;2024-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3